Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jun 21.
Published in final edited form as: ACS Chem Biol. 2019 Jun 10;14(6):1129–1134. doi: 10.1021/acschembio.9b00248

Functional N-substituted N-Thiocarboxyanhydrides as Modular Tools for Constructing H2S Donor Conjugates

Chadwick R Powell 1, Kuljeet Kaur 1, Kearsley M Dillon 1, Mingjun Zhou 1, Mohammed Alaboalirat 1, John B Matson 1,*
PMCID: PMC6911359  NIHMSID: NIHMS1059988  PMID: 31180636

Abstract

We report a synthetic route toward a family of functional COS/H2S-releasing N-substituted N-thiocarboxyanhydrides (NTAs) with functionalities to accommodate popular conjugation reactions, including olefin cross metathesis, thiol-ene, and copper-catalyzed azide-alkyne cycloaddition. The N-substituted NTAs were attached to small molecules, polymers, and a protein to synthesize novel H2S donors convergently. All conjugates showed sustained H2S release kinetics.


Biology has benefitted immensely from the emergence of bioconjugation chemistry. The development of bioconjugates has led to key discoveries in measuring protein/ligand binding, developing effective MRI contrast agents, probing antibody–antigen interactions, and imaging biomolecules in vivo.1 Expanding upon this work, many common bioconjugation reactions also find use in other areas of chemistry, including surface modification2 and polymer functionalization.3 However, bioconjugation strategies have been applied only sparingly in the arena of gasotransmitter research,4-6 which focuses on uncovering the biological roles and exploiting the therapeutic potential of endogenously produced signaling gases. We envisioned that popular bioconjugation reactions could be employed to synthesize a wide variety of gasotransmitter donor conjugates, specifically conjugates capable of delivering hydrogen sulfide (H2S), from a small library of functionalized donors.

As first reported by Abe and Kimura in 1996, H2S is a gasotransmitter.7 Since this discovery, studies on the physiological roles of H2S in the body have ensued.8 More recent discoveries suggest that alterations in endogenous H2S production contribute to a variety of disease states, including cardiovascular disease,9 diabetes,10 and Parkinson’s disease,11 among others.12 These results also indicate that exogenous delivery of H2S may be therapeutic in certain indications by promoting wound healing,13 alleviating cardiovascular tissue damage in ischemia-reperfusion events,14, 15 and mitigating cellular damage in the central nervous system induced by reactive oxygen species (ROS).16 However, compared with existing small molecule H2S donors, donors appended to a variety of compounds and constructs, including established drugs, polymer scaffolds, and proteins, would likely increase the therapeutic viability of exogenous H2S delivery moving forward.

Compared with H2S “donor salts” NaSH and Na2S, which lead to instantaneous release, synthetic H2S donors can incorporate specific release triggers and extend the H2S release half-life, better mimicking endogenous H2S production.17 These properties allow for greater sophistication in studying H2S in biological settings and open avenues for targeted H2S delivery. Over the past decade, various H2S donors have been developed that respond to specific stimuli, including water, nucleophiles, light, and enzymes, among others.18-20 Additionally, current efforts focus on extending H2S donors to polymeric drug delivery systems as well as modifying existing drugs with H2S-releasing moieties.21-28 However, nearly all synthetic H2S donors lack reactive chemical “handles” for use in conjugation reactions, a necessity to develop a library of donors convergently. Based on previous work in our group on donors of carbonyl sulfide (COS), which is converted into H2S in vivo,29 we aimed here to create a platform of dual COS/H2S donors that could be readily conjugated to various scaffolds.

Previously, our lab reported on N-thiocarboxyanhydrides (NTAs) as a class of dual COS/H2S donors with nontoxic, peptidic byproducts.30 NTAs release COS in the presence of primary amines (e.g., glycine), and the ubiquitous enzyme carbonic anhydrase (CA) rapidly catalyzes hydrolysis of the released COS into H2S (Scheme 1A). The initial version of NTAs as COS/H2S donors was the NTA of sarcosine (NTA1) as it offered a straightforward synthesis from commercially available starting materials. However, NTA1 lacks functional handles and is not conducive to conjugation reactions. Therefore, we sought a synthetic route to make NTAs that would tolerate the incorporation of functional groups used in common bioconjugation reactions. Functional NTAs would allow for the simple modification of existing small molecules, polymers, proteins, surfaces, or other platforms with COS/H2S releasing NTAs, opening a range of novel H2S donor systems. To this end, we devised a modular synthetic route to prepare NTAs with several functionalities via the same starting materials. Functional groups with high prevalence in the fields of bioconjugation and polymer chemistry such as alkynes, azides, alkenes, and norbornenes were targeted to allow access to popular conjugation reactions.

Scheme 1.

Scheme 1.

A) Proposed mechanism of COS/H2S release from donor NTA1, studied previously. B) Synthetic route to functional N-substituted NTAs.

N-Functional NTAs were prepared in three steps starting from commercially available 2-((ethoxycarbonothioyl)thio)acetic acid (XAA) and iminodiacetic acid (IDAA) (Scheme 1B), affording thiocarbamate diacetic acid (TCDA). This compound was subsequently monoesterified with commercially available functionalized alcohols to give compounds 1i-v (see Supplemental Information for synthetic routes), followed by ring-closure with phosphorous tribromide (PBr3) to give the corresponding NTAs, labelled NTAs 2–6. To show the versatility of this approach, five N-substituted NTAs were prepared as alkynyl, azido, allyl, norbornyl, and benzyl esters (Scheme 1B). We aimed specifically to synthesize alkynyl- and azido-NTAs (NTA2 and NTA3) to accommodate the Huisgen [3+2] cycloaddition reaction (CuACC) between organo-azides and alkynes. Allyl-NTA (NTA4) was designed to accommodate olefin cross metathesis and thiol-ene reactions, owing to the prevalence of these reactions in bioconjugation and polymer chemistry. Norbornyl-NTA (NTA5) was synthesized to expand the NTAs available for thiol-ene reactions as norbornenes are highly reactive thiol-ene substrates.31 Lastly, benzyl-NTA (NTA6) was synthesized as a model compound to study H2S release from NTAs under various conditions (i.e., different pH and nucleophiles) in detail. All five NTAs are solids at room temperature and stable for months on the benchtop.

To assess whether NTAs decompose under common CuAAC reaction conditions, model reactions on small molecules were conducted. The CuAAC reaction was performed using alkynyl NTA2 and 2-azidoethyl benzoate to form compound 7 (Table 1). The best conditions found for this reaction included a THF/H2O solvent mixture (4:1 v/v) with sonication in lieu of magnetic stirring, as sonication best facilitated the dispersion of the precipitate formed upon addition of sodium ascorbate to copper sulfate pentahydrate (CuSO4·5H2O). Under these conditions, we observed near quantitative conversion into the desired product by 1H NMR spectroscopy in approximately 20 min at rt, with product isolation by flash chromatography (Table 1, compound 7).

Table 1.

Reactions of functional N-substituted NTAs.

Compound N-substituted
NTA
Substrate
(equiv)
Product structure
7 NTA2 2-azidoethyl benzoatea (1) graphic file with name nihms-1059988-t0004.jpg
8 NTA2 Fmoc–Lys(N3)–OHa (1) graphic file with name nihms-1059988-t0005.jpg
9 NTA2 PEG–N3a (0.8) graphic file with name nihms-1059988-t0006.jpg
10 NTA3 THP–propargyl-OH (1)a graphic file with name nihms-1059988-t0007.jpg
11 NTA3 PEG–alkyne (0.8)a graphic file with name nihms-1059988-t0008.jpg
12 NTA4 methyl acrylateb (2) graphic file with name nihms-1059988-t0009.jpg
13 NTA4 Ac–Cys–OHc (1) graphic file with name nihms-1059988-t0010.jpg
14 NTA4 PACMO–SHd (0.5) graphic file with name nihms-1059988-t0011.jpg
15 NTA5 benzyl mercaptanc (1) graphic file with name nihms-1059988-t0012.jpg
16 NTA5 BSAe (0.1) graphic file with name nihms-1059988-t0013.jpg
a

CuSO4·5H2O (0.4 equiv), sodium ascorbate (5 equiv), THF:H2O (4:1 v/v), sonication.

b

Hoveyda-Grubbs Gen. II catalyst, CH2Cl2, reflux, N2 atmosphere.

c

TPO (0.1 equiv), THF, UV irradiation.

d

TPO (0.3 equiv), THF, UV irradiation, N2 atmosphere.

e

TPO (0.05 equiv), H2O:THF (9:1), UV irradiation.

To further highlight the robust nature of the CuAAC reaction with NTA2, we extended the scope of these conditions to conjugation of NTA2 onto an azido-functionalized lysine (Fmoc–Lys(N3)–OH) as well as a macromolecular substrate, azide-terminated poly(ethylene glycol) (PEG–N3, molecular weight (MW) = 5.0 kg/mol). These two substrates were chosen as analogs to peptidic and polymeric drug delivery systems. Using the same reaction conditions outlined above complete conversion to product after approximately 60 min for reactions with both Fmoc–Lys(N3)–OH (Table 1, compound 8) and PEG–N3 (Table 1, compound 9). These reactions demonstrate that a single NTA can be used to functionalize a variety of systems from small molecules to polymers under similar reaction conditions.

In order to fully encompass the scope of the CuAAC click reactions for both alkyne and azide substrates, we synthesized an azide-functionalized NTA, NTA3. To evaluate the reactivity of NTA3, we performed CuAAC on a small molecule model compound, THP-protected propargyl alcohol (Table 1, compound 10), and an alkyne-functionalized PEG (MW = 5.0 kg/mol) (Table 1, compound 11). Both reactions reached complete conversion within 75 min under the same CuAAC conditions described for NTA2.

We also investigated conjugation of NTAs using olefin cross metathesis (CM), a widely used tool in organic chemistry as a facile and mild means of forming carbon-carbon double bonds in bioconjugation,32 drug development,33 and polymer synthesis34. Grubbs and co-workers previously categorized terminal olefin CM substrates into four categories depending on their propensity to form homodimer CM products.35 Ideal CM partners have mismatched reactivity (i.e., Type I + Type II or III), motivating the decision to choose methyl acrylate (Type III) as a model CM partner with allyl-NTA (NTA4) (Type I). CM reactions were conducted in the presence of Hoveyda-Grubbs second generation (HG2) catalyst with p-cresol as an additive, as reported by Tooze and coworkers.36 In the presence of p-cresol and 2 equiv methyl acrylate, complete consumption of NTA4 was observed in 2 h by TLC with 0.1 mol % catalyst loading. The desired NTA-methyl acrylate CM product (85:15 E/Z ratio (Figure S31)) was isolated by flash chromatography (Table 1, compound 12).

The final class of reactions used for NTA conjugation was the radical thiol-ene reaction between thiols and electron-rich alkenes. Thiol-ene reactions can be initiated thermally or by UV light and do not require a metal catalyst, making them particularly attractive bioconjugation reactions. Thiols are commonly found in biological systems in the form of reduced cysteine or glutathione as well as cysteine residues on proteins. Additionally, polymers with thiol chain ends are readily prepared by reversible addition–fragmentation chain transfer (RAFT) polymerization followed by removal of the thio-carbonylthio species,37 offering another mode for conjugation of NTAs to synthetic polymer systems.

For conjugation of NTAs to thiols via thiol-ene, (diphenylphosphoryl)(mesityl)methanone (TPO) was used as the photoinitiator. For the equimolar reaction of NTA4 with N-acetyl cysteine (Ac–Cys–OH) in THF (Table 1, compound 13), complete consumption of the allyl-NTA starting material was observed by TLC in 60 min, with isolation of the conjugate via flash chromatography. The thiol-ene conjugation reaction was then extended to a polymeric system. Water-soluble poly(acryloyl morpholine) (PACMO) was synthesized via RAFT polymerization (MW = 6.0 kg/mol, Ɖ = 1.08), followed by reduction of the trithiocarbonate with hydrazine to reveal a free thiol on the polymer chain end.38 Reaction of this polymeric thiol for 70 min with NTA4 under similar conditions to those described above afforded complete consumption of NTA4. The NTA-PACMO conjugate was easily isolated by precipitation (Table 1, compound 14).

To evaluate the scope of thiol-ene reactions with NTAs, we performed the thiol-ene reaction between NTA4 and bovine serum albumin (BSA), a model protein with a single reduced cysteine residue (Cys34).39 To accommodate the solubility of BSA, a largely aqueous reaction media was employed. Unfortunately, there was no evidence of NTA consumption by TLC after UV irradiation for up to 2 h under these conditions.

Previous reports have demonstrated rapid and efficient light-mediated thiol-ene reactions between substituted norbornenes and thiols in aqueous media.31, 40 This inspired the synthesis of norbornyl-NTA (NTA5) to enable thiol-ene under conditions where NTA4 does not give appreciable conversion. A small molecule model reaction between NTA5 and benzyl mercaptan in the presence of TPO progressed smoothly, reaching full conversion in approximately 60 min (Table 1, compound 15). Using the same reaction conditions attempted with NTA4 and BSA, we observed complete consumption of NTA5 by TLC after 2 h of irradiation with UV light in the presence of TPO. After isolation via precipitation, analysis by MALDI-TOF mass spectrometry revealed a shift in the center of the peak observed for pure BSA from 66,200 to 66,700 m/z (Figure S39), indicating that the conjugation reaction was successful. These results are similar to published MALDI-TOF analyses of modified BSA.41 Successful formation of NTA-functionalized BSA was also confirmed by H2S release measurements (Figure S41).

H2S release profiles of the functional NTAs were investigated using an H2S-selective electrochemical probe in the presence of physiologically relevant concentrations of CA (800 nM). H2S release profiles for the parent NTAs (NTAs 2–6) displayed the typical release profile for small molecule H2S donors, with a rise to a peak concentration followed by a slow return to baseline (Figure 1A). For NTAs 2–6 H2S concentrations peaked between 20–35 min in PBS buffer (pH 7.4) with 100 μM added glycine as a trigger. H2S release from small molecule NTAs after the various functionalization reactions (compounds 7, 8, 10, 12, 13, and 15) did not show a change in the general shape of the H2S release profile from their parent, N-substituted NTA, and peaking times remained within a 15–35 min timeframe (Figure 1B). Although fairly small, we attribute the differences in peaking times between non-polymeric products from the same parent NTA (e.g., compound 7 versus 8 and compound 12 versus 13) to changes in the local environment; for example, the carboxylic acids in compounds 7 and 13 may contribute to their enhanced release rate compared with compounds 8 and 12. Maximum concentrations of H2S in these release profiles are related to peaking time, where a faster peaking time generally leads to a larger maximum H2S concentration. Overall, these results demonstrate that functionalization of NTAs with small molecules does not substantially alter their H2S release profile.

Figure 1.

Figure 1.

A) H2S release data from parent functional NTAs (10 μM) in the presence of Gly (100 μM) and CA (800 nM) in 1X PBS buffer (pH 7.4). B) H2S release data from functionalized NTAs 7-15, see table 1. C) H2S release data from benzyl NTA (10 μM) in the presence of N-α-acetyl-L-lysine (Ac–Lys), glycine (Gly), N-acetyl-L-cysteine (Ac–Cys) in 1X PBS buffer (pH 7.4). D) Plot of peaking times of benzyl NTA (10 μM) vs pH value in various buffered systems (10 mM).

A more dramatic change in H2S release profile was observed for the polymer-NTA conjugates, PEG-NTA (9 and 11) and PACMO-NTA (14). All of the polymer-NTA conjugates showed substantially lower maximum concentrations of H2S relative to the small molecule NTAs at the same concentration, with peaking times occurring at 20 min for the PACMO-NTA conjugate (14) and approximately 2 h for the PEG-NTA conjugates (9 and 11). Despite the differences in peaking times, all of the macromolecular NTA conjugates showed a more gradual return to baseline H2S concentrations relative to the small molecule NTA donors, demonstrating that polymeric donors are capable of maintaining a sustained concentration of H2S in solution to a greater degree than the small molecule NTAs. The phenomenon of extended and sustained H2S release from polymeric H2S donors has been previously reported, and it likely stems from steric effects of the polymer chain in solution.21, 22, 30

To gather further insight into the H2S release kinetics of N-substituted NTAs, benzyl-NTA (NTA6) was used as a model substrate in the presence of various biologically relevant nucleophiles and at different pH values. In the first set of experiments with NTA6, we explored the effect of various nucleophiles on H2S release rate under pseudo-first-order conditions (10:1 molar ratio of nucleophile to NTA). The nucleophiles included water only (hydrolysis), glycine, Ac–Lys–OH, and Ac–Cys–OH and were chosen to provide a range of functionalities available in vivo. Each nucleophile tested gave a similar release profile to hydrolysis, with addition of Ac–Lys–OH leading to a moderate decrease in peaking time and a greater maximum H2S concentration (Figure 1C) than the others, indicating a faster overall release.

Release of H2S from NTA6 was also measured in buffers at various pH values. Peaking times remained constant within experimental error between pH 6 and 8.8, with peaking times ranging from 20–25 min at each pH value (Figure 1D). Taken together, these results demonstrate that NTAs provide a platform with consistent COS/H2S release rates under a variety of physiologically relevant pH values.

Lastly, we assessed the cytotoxicity of NTA6 in the presence of H9C2 cardiomyocytes (Figure 2). NTA6 showed no effect on cell viability at concentrations ≤200 μM after incubation for 24 h, relative to untreated controls. These results stand in contrast to previous reports on cell viability of other COS donors, which display significant cytotoxicity at concentrations below 100 μM in certain cell lines..19, 42, 43

Figure 2.

Figure 2.

Viability of H9C2 cardiomyoctyes treated with NTA6 at various concentrations. Viability is presented as a percentage relative to a media-only control. Quantification of viability was carried out using Cell Counting Kit-8 (CCK-8). Results are expressed as the mean ± SEM (n = 3 for each treatment group, where 8-10 trials were run for each independent experiment).

In summary, we have validated functional N-substituted NTAs as a modular donor platform from which a wide variety of H2S donor conjugates may be prepared. Herein, we have presented a synthetic route to a variety of functional NTAs, which can subsequently be used to modify existing drugs, macromolecules, or proteins to form COS/H2S-releasing conjugates. NTAs release H2S spontaneously in CA-containing water but at a faster rate when triggered with an amine. Synthesis of NTA conjugates in aqueous conditions was successful, which will inform preparation of H2S-donating proteins or water-soluble polymers. An assortment of H2S donor systems will further facilitate the study of COS/H2S physiology and help fully realize the therapeutic benefits of exogenous H2S delivery.

Supplementary Material

SI

ACKNOWLEDGMENTS

This work was supported by the National Science Foundation (DMR-1454754), the National Institutes of Health (R01GM123508), and the Dreyfus foundation. The authors acknowledge Y Wang for his help with cell culture, R. Gandour for critical reading of the manuscript, as well as M. Ashraf-Khorassani and R. Helm for their assistance with high-resolution mass spectrometry.

Footnotes

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website as a PDF file.

Experimental details, synthetic procedures and compound characterization

The authors declare no competing financial interests.

REFERENCES

  • (1).Kalia J, and Raines RT (2010) Advances in Bioconjugation, Curr. Org. Chem 14, 138–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Binder WH, and Sachsenhofer R (2007) ‘Click’ Chemistry in Polymer and Materials Science, Macromol. Rapid Commun 28, 15–54. [Google Scholar]
  • (3).Le Droumaguet B, and Velonia K (2008) Click Chemistry: A Powerful Tool to Create Polymer-Based Macromolecular Chimeras, Macromol. Rapid Commun 29, 1073–1089. [Google Scholar]
  • (4).Oladeinde OA, Hong SY, Holland RJ, Maciag AE, Keefer LK, Saavedra JE, and Nandurdikar RS (2010) “Click” Reaction in Conjunction with Diazeniumdiolate Chemistry: Developing High-Load Nitric Oxide Donors, Org. Lett. 12, 4256–4259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).Zhang J, Song H, Ji S, Wang X, Huang P, Zhang C, Wang W, and Kong D (2018) NO Prodrug-conjugated, Self-assembled, pH-responsive and Galactose Receptor Targeted Nanoparticles for Co-delivery of Nitric Oxide and Doxorubicin, Nanoscale 10, 4179–4188. [DOI] [PubMed] [Google Scholar]
  • (6).Nguyen D, Oliver S, Adnan NNM, Herbert C, and Boyer C (2016) Polymer–protein Hybrid Scaffolds as Carriers for CORM-3: Platforms for the Delivery of Carbon Monoxide (CO), RSC Advances 6, 92975–92980. [Google Scholar]
  • (7).Abe K, and Kimura H (1996) The Possible Role of Hydrogen Sulfide as an Endogenous Neuromodulator, J. Neurosci 16, 1066–1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Cuevasanta E, Möller MN, and Alvarez B (2017) Biological Chemistry of Hydrogen Sulfide and Persulfides, Arch. Biochem. Biophys 617, 9–25. [DOI] [PubMed] [Google Scholar]
  • (9).Lefer DJ (2007) A New Gaseous Signaling Molecule Emerges: Cardioprotective Role of Hydrogen Sulfide, Proc. Natl. Acad. Sci. U. S. A 104, 17907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Kaneko Y, Kimura Y, Kimura H, and Niki I (2006) L-cysteine Inhibits Insulin Release from the Pancreatic Beta-cell: Possible Involvement of Metabolic Production of Hydrogen Sulfide, a Novel Gasotransmitter, Diabetes 55, 1391–1397. [DOI] [PubMed] [Google Scholar]
  • (11).Hu L-F, Lu M, Tiong CX, Dawe GS, Hu G, and Bian J-S (2010) Neuroprotective Effects of Hydrogen Sulfide on Parkinson’s Disease Rat Models, Aging Cell 9, 135–146. [DOI] [PubMed] [Google Scholar]
  • (12).Kashfi K, and Olson KR (2013) Biology and Therapeutic Potential of Hydrogen Sulfide and Hydrogen Sulfide-releasing Chimeras, Biochem. Pharmacol 85, 689–703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R, and Szabó C (2009) Hydrogen Sulfide is an Endogenous Stimulator of Angiogenesis, Proc. Natl. Acad. Sci. U. S. A 106, 21972–21977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Zhao Y, Bhushan S, Yang C, Otsuka H, Stein JD, Pacheco A, Peng B, Devarie-Baez NO, Aguilar HC, Lefer DJ, and Xian M (2013) Controllable Hydrogen Sulfide Donors and Their Activity against Myocardial Ischemia-Reperfusion Injury, ACS Chem. Biol 8, 1283–1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, and Lefer DJ (2009) Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling, Circ. Res 105, 365–374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (16).Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL, Wong BS, Armstrong JS, and Moore PK (2005) Hydrogen Sulphide: A Novel Inhibitor of Hypochlorous Acid-mediated Oxidative Damage in the Brain?, Biochem. Biophys. Res. Commun 326, 794–798. [DOI] [PubMed] [Google Scholar]
  • (17).Zhao Y, Biggs TD, and Xian M (2014) Hydrogen Sulfide (H2S) Releasing Agents: Chemistry and Biological Applications, Chem. Commun 50, 11788–11805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).Powell CR, Dillon KM, and Matson JB (2018) A Review of Hydrogen Sulfide (H2S) Donors: Chemistry and Potential Therapeutic Applications, Biochem. Pharmacol 149, 110–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Steiger AK, Yang Y, Royzen M, and Pluth MD (2017) Bioorthogonal “Click-and-Release” Donation of Caged Carbonyl Sulfide (COS) and Hydrogen Sulfide (H2S), Chem. Commun 53, 1378–1380. [DOI] [PubMed] [Google Scholar]
  • (20).Ji X, Zhou C, Ji K, Aghoghovbia RE, Pan Z, Chittavong V, Ke B, and Wang B (2016) Click and Release: A Chemical Strategy toward Developing Gasotransmitter Prodrugs by Using an Intramolecular Diels–Alder Reaction, Angew. Chem. Int. Ed 55, 15846–15851. [DOI] [PubMed] [Google Scholar]
  • (21).Foster JC, and Matson JB (2014) Functionalization of Methacrylate Polymers with Thiooximes: A Robust Postpolymerization Modification Reaction and a Method for the Preparation of H2S-Releasing Polymers, Macromolecules 47, 5089–5095. [Google Scholar]
  • (22).Xiao Z, Bonnard T, Shakouri-Motlagh A, Wylie RAL, Collins J, White J, Heath DE, Hagemeyer CE, and Connal LA (2017) Triggered and Tunable Hydrogen Sulfide Release from Photogenerated Thiobenzaldehydes, Chem. Eur. J 23, 11294–11300. [DOI] [PubMed] [Google Scholar]
  • (23).Urquhart MC, Ercole F, Whittaker MR, Boyd BJ, Davis TP, and Quinn JF (2018) Recent Advances in the Delivery of Hydrogen Sulfide via a Macromolecular Approach, Polym. Chem 9, 4431–4439. [Google Scholar]
  • (24).Lee M, McGeer E, Kodela R, Kashfi K, and McGeer PL (2013) NOSH-aspirin (NBS-1120), a Novel Nitric Oxide and Hydrogen Sulfide Releasing Hybrid, Attenuates Neuroinflammation Induced by Microglial and Astrocytic Activation: A New Candidate for Treatment of Neurodegenerative Disorders, Glia 61, 1724–1734. [DOI] [PubMed] [Google Scholar]
  • (25).Hasegawa U, Tateishi N, Uyama H, and van der Vlies AJ (2015) Hydrolysis-Sensitive Dithiolethione Prodrug Micelles, Macromol. Biosci 15, 1512–1522. [DOI] [PubMed] [Google Scholar]
  • (26).Sidhapuriwala J, Li L, Sparatore A, Bhatia M, and Moore PK (2007) Effect of S-diclofenac, a Novel Hydrogen Sulfide Releasing Derivative, on Carrageenan-induced Hindpaw Oedema Formation in the Rat, Eur. J. Pharmacol 569, 149–154. [DOI] [PubMed] [Google Scholar]
  • (27).Marutani E, Sakaguchi M, Chen W, Sasakura K, Liu J, Xian M, Hanaoka K, Nagano T, and Ichinose F (2014) Cytoprotective Effects of Hydrogen Sulfide-releasing N-methyl-D-aspartate Receptor Antagonists are Mediated by Intracellular Sulfane Sulfur, MedChemComm 5, 1577–1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (28).Cenac N, Castro M, Desormeaux C, Colin P, Sie M, Ranger M, and Vergnolle N (2016) A Novel Orally Administered Trimebutine Compound (GIC-1001) is Anti-nociceptive and Features Peripheral Opioid Agonistic Activity and Hydrogen Sulphide-releasing Capacity in Mice, Eur. J. Pain 20, 723–730. [DOI] [PubMed] [Google Scholar]
  • (29).Chengelis CP, and Neal RA (1979) Hepatic Carbonyl Sulfide Metabolism, Biochem. Biophys. Res. Commun 90, 993–999. [DOI] [PubMed] [Google Scholar]
  • (30).Powell CR, Foster JC, Okyere B, Theus MH, and Matson JB (2016) Therapeutic Delivery of H2S via COS: Small Molecule and Polymeric Donors with Benign Byproducts, J. Am. Chem. Soc 138, 13477–13480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (31).Fairbanks BD, Schwartz MP, Halevi AE, Nuttelman CR, Bowman CN, and Anseth KS (2009) A Versatile Synthetic Extracellular Matrix Mimic via Thiol-Norbornene Photopolymerization, Adv. Mater 21, 5005–5010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (32).Qin L-H, Hu W, and Long Y-Q (2018) Bioorthogonal Chemistry: Optimization and Application Updates during 2013-2017, Tetrahedron Lett. 59, 2214–2228. [Google Scholar]
  • (33).Dragutan I, Dragutan V, and Demonceau A (2012) Targeted Drugs by Olefin Metathesis: Piperidine-based Iminosugars, RSC Advances 2, 719–736. [Google Scholar]
  • (34).Dong Y, Matson JB, and Edgar KJ (2017) Olefin Cross-Metathesis in Polymer and Polysaccharide Chemistry: A Review, Biomacromolecules 18, 1661–1676. [DOI] [PubMed] [Google Scholar]
  • (35).Chatterjee AK, Choi T-L, Sanders DP, and Grubbs RH (2003) A General Model for Selectivity in Olefin Cross Metathesis, J. Am. Chem. Soc 125, 11360–11370. [DOI] [PubMed] [Google Scholar]
  • (36).Forman GS, and Tooze RP (2005) Improved Cross-Metathesis of Acrylate Esters Catalyzed by 2nd Generation Ruthenium Carbene Complexes, J. Organomet. Chem 690, 5863–5866. [Google Scholar]
  • (37).Willcock H, and O'Reilly RK (2010) End Group Removal and Modification of RAFT Polymers, Polym. Chem 1, 149–157. [Google Scholar]
  • (38).Shen W, Qiu Q, Wang Y, Miao M, Li B, Zhang T, Cao A, and An Z (2010) Hydrazine as a Nucleophile and Antioxidant for Fast Aminolysis of RAFT Polymers in Air, Macromol. Rapid Commun 31, 1444–1448. [DOI] [PubMed] [Google Scholar]
  • (39).Oettl K, and Stauber RE (2007) Physiological and Pathological Changes in the Redox State of Human Serum Albumin Critically Influence its Binding Properties, Br. J. Pharmacol 151, 580–590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (40).Lin C-C, Ki CS, and Shih H (2015) Thiol-norbornene Photo-click Hydrogels for Tissue Engineering Applications, J. Appl. Polym. Sci 132, 41563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (41).Chen Y, and Hagerman AE (2004) Characterization of Soluble Non-covalent Complexes between Bovine Serum Albumin and β−1,2,3,4,6-Penta-O-galloyl-d-glucopyranose by MALDI-TOF MS, J. Agric. Food Chem 52, 4008–4011. [DOI] [PubMed] [Google Scholar]
  • (42).Zhao Y, and Pluth MD (2016) Hydrogen Sulfide Donors Activated by Reactive Oxygen Species, Angew. Chem. Int. Ed 55, 14638–14642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (43).Steiger AK, Marcatti M, Szabo C, Szczesny B, and Pluth MD (2017) Inhibition of Mitochondrial Bioenergetics by Esterase-Triggered COS/H2S Donors, ACS Chem. Biol 12, 2117–2123. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES